Nurse Practitioner · Wausau, WI
NPI
1205814464
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
500 Wind Ridge Dr
Wausau, WI, 54401
Phone (715) 847-2611
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
1,266 services
Medicare patients, 2024
219
Average age 76
Drug cost, 2024
$1.1M
3,669 prescriptions
Company payments, 2025
$53K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Melissa J Wendell was code 80047 (clinical chemistry), 357 times for 165 patients. In total Melissa J Wendell billed 1,266 services in 19 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-11-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80047 Clinical Chemistry | Office | 357 | 165 | $13.46 | $4,805 |
| 99214 Office E&M - Established | Office | 332 | 162 | $75.77 | $25K |
| 36415 Venipuncture Blood Collection | Office | 268 | 136 | $8.65 | $2,318 |
| 93264 External Electrocardiographic Monitoring | Office | 119 | 37 | $28.18 | $3,353 |
| 85014 Blood Count | Office | 88 | 42 | $2.32 | $204 |
| 99215 Office E&M - Established | Office | 21 | 16 | $101.19 | $2,125 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 21 | 18 | $178.53 | $3,749 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 19 | 18 | $132.71 | $2,522 |
By year: 2022 $38K for 943 services; 2023 $45K for 1,220 services; 2024 $45K for 1,266 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80047 Clinical Chemistry | 357 | 165 | $13.46 | $4,805 |
| 36415 Venipuncture Blood Collection | 268 | 136 | $8.65 | $2,318 |
| 85014 Blood Count | 88 | 42 | $2.32 | $204 |
Medicare prescription drug claims, 2024
In 2024, the drug Melissa J Wendell prescribed most often to Medicare patients was Bumetanide, with 593 prescriptions and refills. In total Melissa J Wendell wrote 3,669 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Bumetanide Generic | 593 | 1,178 | 167 | $26K |
| Entresto Sacubitril/Valsartan | 444 | 576 | 86 | $379K |
| Jardiance Empagliflozin | 327 | 520 | 81 | $304K |
| Spironolactone Generic | 325 | 657 | 112 | $1,907 |
| Metoprolol Succinate Generic | 310 | 727 | 107 | $3,922 |
| Potassium Chloride Generic | 227 | 503 | 84 | $5,893 |
| Eliquis Apixaban | 172 | 273 | 43 | $155K |
| Atorvastatin Calcium Generic | 140 | 360 | 48 | $1,245 |
| Furosemide Generic | 122 | 292 | 41 | $684 |
| Carvedilol Generic | 121 | 327 | 48 | $856 |
| Losartan Potassium Generic | 81 | 209 | 31 | $443 |
| Torsemide Generic | 77 | 202 | 31 | $2,068 |
| Amiodarone Hcl Generic | 59 | 134 | 26 | $684 |
| Clopidogrel Clopidogrel Bisulfate | 57 | 136 | 21 | $571 |
| Amlodipine Besylate Generic | 56 | 125 | 17 | $276 |
Brand drugs: 1,090 claims; generic drugs: 2,579 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Melissa J Wendell $53K ($53K in general payments such as food, travel and fees) from 13 companies. The largest payer was CVRx, Inc. with $23K.
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. CVRX | 51 | $23K |
| Abbott Laboratories ABT | 57 | $22K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $5,134 |
| Lilly USA, LLC LLY | 5 | $1,751 |
| Endotronix, Inc. | 1 | $251 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $140 |
| Abiomed JNJ | 2 | $139 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $125 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.